Determining How Certain Recurrent Breast Cancer Patients Will Respond To Therapy
 

Research introduced at SNM's 57th Annual Meeting is expanding molecular imaging's role in determining the best course of treatment for recurring breast cancer patients, while offering a means of evaluating certain therapies for potentially positive impact on their chance of survival...

More...